Patent · US Active

Selective CCR2 antagonists

US9108958B2 · kind B2 · utility

4Cited by

17References

13Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Heiner Ebel · Biberach an der Riß, DE
Sara Frattini · Castelleone, IT
Riccardo Giovannini · Verona, IT
Stefan Scheuerer · Warthausen, DE

Key dates

Filing date	Jul 13, 2012
Grant date	Aug 18, 2015
Priority date	—
Expiry date	Mar 21, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel and selective antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD as well as pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.